George S. Sopko

Q: What Schools Are Affiliated With George S. Sopko

George S. Sopko is affiliated with the following schools: University of California, Berkeley, Boston University, Emory University, Stanford University, University of Pittsburgh, Duke University

George S. Sopko's AcademicInfluence.com Rankings

George S. Sopko

Engineering

#6958

World Rank

#8315

Historical Rank

Electrical Engineering

#2125

World Rank

#2230

Historical Rank

engineering Degrees

George S. Sopko

Computer Science

#9295

World Rank

#9762

Historical Rank

Computational Linguistics

#2221

World Rank

#2243

Historical Rank

Machine Learning

#4033

World Rank

#4081

Historical Rank

Artificial Intelligence

#4370

World Rank

#4430

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

George S. Sopko's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026

Why Is George S. Sopko Influential?

(Suggest an Edit or Addition)

(See a Problem?)

George S. Sopko's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. (2011) (1730)
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. (1996) (1401)
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. (2011) (895)
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. (2007) (873)
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. (2006) (807)
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women (2004) (788)
Acute Heart Failure Syndromes: Current State and Framework for Future Research (2005) (731)
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. (2006) (706)
Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. (2005) (655)
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. (2010) (652)
Coronary bypass surgery with or without surgical ventricular reconstruction. (2009) (646)
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. (2016) (606)
Coronary intervention for persistent occlusion after myocardial infarction. (2006) (599)
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. (2012) (585)
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG. (1995) (580)
Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. (1995) (526)
Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. (2001) (508)
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women (2004) (492)
Coronary-artery bypass surgery in patients with left ventricular dysfunction. (2011) (478)
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. (1997) (477)
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. (2008) (461)
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade (2017) (421)
Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) (2004) (410)
Survival after application of automatic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million. (2010) (407)
Relationship Between Chest Compression Rates and Outcomes From Cardiac Arrest (2012) (389)
Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women: Results From the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) (2004) (356)
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. (2016) (353)
The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. (1999) (343)
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. (1991) (322)
Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: Baseline Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial (2014) (320)
Navigating the Crossroads of Coronary Artery Disease and Heart Failure (2006) (312)
Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) (1998) (301)
The Economic Burden of Angina in Women With Suspected Ischemic Heart Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (2006) (298)
Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). (2001) (279)
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. (2003) (275)
Symptom presentation of women with acute coronary syndromes: myth vs reality. (2007) (274)
Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. (2007) (266)
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. (2005) (262)
Early versus later rhythm analysis in patients with out-of-hospital cardiac arrest. (2011) (257)
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. (2004) (255)
Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). (1999) (254)
Metabolic Syndrome Modifies the Cardiovascular Risk Associated With Angiographic Coronary Artery Disease in Women: A Report From the Women’s Ischemia Syndrome Evaluation (2004) (249)
The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction (2009) (245)
Effect of a Strategy of Initial Laryngeal Tube Insertion vs Endotracheal Intubation on 72-Hour Survival in Adults With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial (2018) (243)
Evidence-based guidelines for cardiovascular disease prevention in women. (2004) (243)
Out-of-hospital Hypertonic Resuscitation After Traumatic Hypovolemic Shock: A Randomized, Placebo Controlled Trial (2011) (241)
Chest Compression Rates and Survival Following Out-of-Hospital Cardiac Arrest* (2015) (240)
Trial of Continuous or Interrupted Chest Compressions during CPR. (2015) (225)
The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE). (2009) (216)
A trial of an impedance threshold device in out-of-hospital cardiac arrest. (2011) (211)
Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. (1999) (194)
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. (2007) (190)
Long-Term Clinical Outcome in the Bypass Angioplasty Revascularization Investigation Registry Comparison With the Randomized Trial (2000) (189)
Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. (1995) (188)
Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration Workshop Report. Consensus Statement. (2000) (184)
Some thoughts on the vasculopathy of women with ischemic heart disease. (2006) (183)
Relationship of physical fitness vs body mass Index with coronary artery disease and cardiovascular events in women (2004) (181)
Depression, the Metabolic Syndrome and Cardiovascular Risk (2008) (179)
Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. (2010) (178)
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. (2012) (172)
The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. (2000) (171)
Non–High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI) (2002) (167)
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia (2011) (166)
Randomized Trial of Percutaneous Coronary Intervention for Subacute Infarct-Related Coronary Artery Occlusion to Achieve Long-Term Patency and Improve Ventricular Function: The Total Occlusion Study of Canada (TOSCA)–2 Trial (2006) (165)
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). (2010) (162)
Cardiac Dysfunction and Mortality in HIV-Infected Children: The Prospective P2C2 HIV Multicenter Study (2000) (150)
Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST‐CLI) Trial (2016) (145)
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. (2006) (145)
Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop. (2013) (144)
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. (2008) (143)
Changing preferences for survival after hospitalization with advanced heart failure. (2008) (142)
Social Networks Are Associated With Lower Mortality Rates Among Women With Suspected Coronary Disease: The National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation Study (2004) (137)
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. (2000) (134)
Left ventricular form and function: scientific priorities and strategic planning for development of new views of disease. (2004) (132)
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women. (2019) (130)
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. (2001) (130)
Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. (2003) (128)
Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. (2000) (126)
Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies (2001) (125)
Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. (2019) (125)
Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. (1997) (124)
Bypass Angioplasty Revascularization Investigation: patient screening, selection, and recruitment. (1995) (124)
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. (1994) (123)
Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury. (2020) (120)
Mild Renal Insufficiency Is Associated With Angiographic Coronary Artery Disease in Women (2002) (119)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary. (2004) (119)
Pre-hospital 12-lead electrocardiography programs: a call for implementation by emergency medical services systems providing advanced life support--National Heart Attack Alert Program (NHAAP) Coordinating Committee; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health. (2006) (112)
Impact of Bystander Automated External Defibrillator Use on Survival and Functional Outcomes in Shockable Observed Public Cardiac Arrests (2018) (109)
The effects of exercise and weight loss on plasma lipids in young obese men. (1985) (109)
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. (2004) (106)
Out-of-hospital cardiac arrest frequency and survival: evidence for temporal variability. (2010) (101)
Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction (1995) (99)
Dobutamine stress echocardiography in women with chest pain. Pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). (1999) (98)
Surgical therapy for coronary artery disease among patients with combined coronary artery and peripheral vascular disease. (1995) (96)
Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. (2010) (95)
Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) (2007) (92)
Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA. A report from the NHLBI PTCA Registry. (1998) (89)
Genetic Variation in Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 (LOX1) Gene and the Risk of Coronary Artery Disease (2003) (89)
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study. (2006) (85)
Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study. (2002) (84)
Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study. (2005) (83)
Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study. (2006) (82)
National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. (2010) (82)
Reliability of Multicenter Pediatric Echocardiographic Measurements of Left Ventricular Structure and Function: The Prospective P2C2 HIV Study (2001) (80)
Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study. (1995) (80)
The PULSE initiative: scientific priorities and strategic planning for resuscitation research and life saving therapies. (2002) (78)
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. (2005) (78)
Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial. (1993) (77)
Large brachial artery diameter is associated with angiographic coronary artery disease in women. (2002) (76)
Women and cardiovascular heart disease: clinical implications from the Women's Ischemia Syndrome Evaluation (WISE) Study. Are we smarter? (2006) (73)
Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot Investigators. (1996) (71)
A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study angiographic core laboratory. (1997) (70)
Effect of gender on outcome of out of hospital cardiac arrest in the Resuscitation Outcomes Consortium. (2010) (70)
Core lab analysis of baseline echocardiographic studies in the STICH trial and recommendation for use of echocardiography in future clinical trials. (2012) (70)
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. (2004) (69)
Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction. (2012) (68)
Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial (2015) (67)
Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). (1998) (67)
Electrocardiographic predictors of cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. (2005) (66)
Psychosocial Variables Are Associated With Atherosclerosis Risk Factors Among Women With Chest Pain: The WISE Study (2001) (66)
Cardiac Complications in Children With Human Immunodeficiency Virus Infection (1999) (65)
Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI). (1999) (64)
Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: implications for clinical practice. (2003) (64)
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome. (2016) (62)
Effect of Intensive Lipid Lowering, With or Without Antioxidant Vitamins, Compared With Moderate Lipid Lowering on Myocardial Ischemia in Patients With Stable Coronary Artery Disease: The Vascular Basis for the Treatment of Myocardial Ischemia Study (2005) (60)
Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries. (1998) (60)
Depression Is Associated With Cardiac Symptoms, Mortality Risk, and Hospitalization Among Women With Suspected Coronary Disease: The NHLBI-Sponsored WISE Study (2006) (56)
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2008) (55)
Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study. (2000) (55)
Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment. (2019) (54)
APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study. (2003) (54)
Anger, hostility, and cardiac symptoms in women with suspected coronary artery disease: the Women's Ischemia Syndrome Evaluation (WISE) Study. (2006) (53)
Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Thrombolysis in Myocardial Infarction Investigators. (1995) (53)
Migraines, angiographic coronary artery disease and cardiovascular outcomes in women. (2006) (51)
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study. (2006) (51)
Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE) (2017) (51)
Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study) (1997) (50)
Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. (2000) (49)
Effect of Phosphodiesterase Type 5 Inhibition on Microvascular Coronary Dysfunction in Women: A Women's Ischemia Syndrome Evaluation (WISE) Ancillary Study (2011) (47)
Hostility Scores Are Associated With Increased Risk of Cardiovascular Events in Women Undergoing Coronary Angiography: A Report from the NHLBI-Sponsored WISE Study (2005) (47)
Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group. (1997) (44)
Coronary Revascularization in Diabetic Patients (1999) (44)
STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment. (2010) (43)
History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. (2001) (42)
Trauma in the neighborhood: a geospatial analysis and assessment of social determinants of major injury in North America. (2011) (42)
Socioeconomic Status Variables Predict Cardiovascular Disease Risk Factors and Prospective Mortality Risk among Women with Chest Pain (2003) (41)
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes. The ACIP Investigators. (1995) (41)
Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study). (1996) (40)
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) (2017) (39)
Determinants and prognostic information provided by pulse pressure in patients with coronary artery disease undergoing revascularization. The Balloon Angioplasty Revascularization Investigation (BARI). (2001) (39)
Global health and emergency care: a resuscitation research agenda--part 1. (2013) (39)
Guidelines for development and use of transluminally placed endovascular prosthetic grafts in the arterial system. (1995) (38)
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2010) (38)
Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the Bypass Angioplasty Revascularization Investigation study (BARI). (1996) (38)
Clinical and operative characteristics of patients randomized to coronary artery bypass surgery in the Bypass Angioplasty Revascularization Investigation (BARI). (1995) (38)
Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest (2020) (38)
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. (2022) (37)
Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients. (2000) (37)
Race and Prognosis After Myocardial Infarction Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial (1993) (37)
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2009) (36)
Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS). (1997) (36)
Regulatory Challenges for the Resuscitation Outcomes Consortium (2008) (36)
Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study (2011) (35)
Renal Function and Coronary Microvascular Dysfunction in Women with Symptoms/Signs of Ischemia (2015) (35)
Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation. (2014) (35)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials. (2004) (35)
Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment. (2019) (35)
Predictors of Mortality and Mortality From Cardiac Causes in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial and Registry (2000) (33)
Association between β-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study (2005) (33)
Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland. (1998) (33)
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (2011) (33)
Detection and Management of Geographic Disparities in the TOPCAT Trial (2016) (32)
Asymptomatic Cardiac Ischemia Pilot study (ACIP) (1992) (31)
Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). (2008) (31)
Workshop Executive Summary Report: Post-resuscitative and initial Utility in Life Saving Efforts (PULSE): June 29-30, 2000; Lansdowne Resort and Conference Center; Leesburg, VA. (2001) (31)
Clinical Implications of the Women's Ischemia Syndrome Evaluation: Inter-Relationships Between Symptoms, Psychosocial Factors and Cardiovascular Outcomes (2013) (30)
Dietary measures of physical activity. (1984) (30)
Influence of Crossover on Mortality in a Randomized Study of Revascularization in Patients With Systolic Heart Failure and Coronary Artery Disease (2013) (30)
Phytoestrogens and lipoproteins in women. (2006) (30)
Posttraumatic Stress Disorder and Cardiovascular Disease: State of the Science, Knowledge Gaps, and Research Opportunities. (2021) (30)
Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). (1999) (29)
Combined α/β‐blockade versus β1‐selective blockade in essential hypertension in black and white patients (1990) (29)
Bairey Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood (Women's Ischemia Syndrome Evaluation) study. Coll Cardiol ;. (2010) (29)
Risk stratification after successful coronary revascularization: the lack of a role for routine exercise testing. (2001) (28)
Smoking, physical activity, and other predictors of endurance and heart rate response to exercise in asymptomatic hypercholesterolemic men. The Lipid Research Clinics Coronary Primary Prevention Trial. (1987) (28)
Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study. (2003) (28)
Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow‐up from the STICH trial (2015) (27)
Multimarker Approach Predicts Adverse Cardiovascular Events in Women Evaluated for Suspected Ischemia: Results from the National Heart, Lung, and Blood Institute–Sponsored Women's Ischemia Syndrome Evaluation (2009) (27)
Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE). (2002) (25)
Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study. (2016) (24)
Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome Evaluation. (2017) (24)
Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial (2014) (24)
The STICH trial: evidence‐based conclusions (2010) (23)
Preventing cardiac events and restenosis after percutaneous coronary intervention. (2002) (22)
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. (2007) (22)
Short and long term outcome of percutaneous transluminal coronary angioplasty in unstable versus stable angina pectoris: a report of the 1985-1986 NHLBI PTCA Registry. (1991) (22)
Clinical trials in the out-of-hospital setting: Rationale and strategies for successful implementation (2009) (22)
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Relationship between exercise-induced and ambulatory ischemia in patients with stable coronary disease. (1996) (22)
Sample size calculation for clinical trials in which entry criteria and outcomes are counts of events (1994) (21)
Hospital Variation in the Utilization and Implementation of Targeted Temperature Management in Out-of-Hospital Cardiac Arrest (2018) (21)
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study (2017) (21)
Postmortem cardiomegaly and echocardiographic measurements of left ventricular size and function in children infected with the human immunodeficiency virus. The Prospective P2C2 HIV Multicenter Study. (2003) (20)
Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study. (2018) (20)
Hypothermia and hemostasis in severe trauma: A new crossroads workshop report (2012) (20)
Outcomes With the Use of Bag-Valve-Mask Ventilation During Out-of-hospital Cardiac Arrest in the Pragmatic Airway Resuscitation Trial. (2020) (20)
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease (2005) (19)
Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. (2004) (19)
Cardiac, Aortic, and Pulmonary Arteriopathy in HIV-infected children: The Prospective P2C2 HIV Multicenter Study (2004) (19)
Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients. (1990) (19)
Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators. (2000) (18)
Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2015) (17)
Is the enrollment of racial and ethnic minorities in research in the emergency setting equitable? (2009) (17)
Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) (2019) (17)
Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE). (2008) (17)
RELATION OF TREADMILL EXERCISE TEST PERFORMANCE TO HABITUAL VIGOROUS EXERCISE AND CORONARY RISK FACTORS IN APPARENTLY HEALTHY HYPERCHOLESTEREMIC MEN (1985) (16)
Renin‐Angiotensin and Sympathetic Nervous System Activity in Grade School Children (1982) (16)
Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: Results from the nhlbi wise study (2002) (16)
Controlled trial of acifran in type II hyperlipoproteinemia (1985) (15)
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. (2013) (15)
Genetic loci associated with nonobstructive coronary artery disease in Caucasian women. (2016) (14)
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease. (2005) (14)
Organizational structure and communication strategies of the bypass angioplasty revascularization investigation: a multicenter clinical trial. (1996) (14)
Effects on blood lipids and body weight in high risk men of a practical exercise program. (1983) (14)
A call to standardize symptom presentation in acute coronary syndromes. (2012) (12)
The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial (2018) (12)
Post resuscitative and initial utility in life saving efforts (pulse): a workshop executive summary. (2001) (11)
Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics. (2004) (11)
Elevated blood pressure in school children--prevalence, persistence, and hemodynamics: the Minneapolis Children's Blood Pressure Study. (1983) (11)
Trends in coronary revascularization 1989 to 1997: the Bypass Angioplasty Revascularization Investigation (BARI) survey of procedures. (1999) (10)
Burden of medical co‐morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy (2019) (10)
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain (2004) (10)
Overview of the National Heart, Lung, and Blood Institute Workshop on physical activity and cardiovascular health. (1992) (9)
Report of the National Heart, Lung and Blood Institute-National Institute of Allergy and Infectious Diseases working group on antimicrobial strategies and cardiothoracic surgery. (2004) (9)
Workshop executive summary report: Postresuscitative and initial utility in life-saving efforts (PULSE), June 29–30, 2000, Lansdowne Resort and Conference Center, Leesburg, VA (2001) (9)
Intracranial hemorrhage after rt-pa and heparin for acute myocardial infarction — The TIMI II pilot and randomized trial combined experience (1990) (9)
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT). (2009) (9)
EARLY-ONSET MENOPAUSAL VASOMOTOR SYMPTOMS ARE ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION: THE NATIONAL HEART LUNG AND BLOOD INSTITUTE-SPONSORED WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY (2015) (8)
Relation of coagulation parameters to patency and recurrent ischemia in the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. (1998) (8)
Centralized IRB models for emergency care research. (2014) (8)
The resuscitation outcomes consortium (ROC) primed impedance threshold device (ITD) cardiac arrest trial: A prospective, randomised, double-blind, controlled clinical trial (2010) (7)
Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. (2007) (7)
re-Hospital 12-Lead Electrocardiography Programs (2006) (7)
Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigators. (1997) (7)
Airway Insertion First Pass Success and Patient Outcomes in Adult Out-of-Hospital Cardiac Arrest: The Pragmatic Airway Resuscitation Trial. (2020) (7)
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT). (2012) (6)
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). (1999) (6)
Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation (2022) (6)
Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design (2008) (6)
ASSOCIATION OF ABNORMAL ELECTROCARDIOGRAPHY RESPONSE ON STRESS ECHOCARDIOGRAM WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS IN WOMEN: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY (2021) (5)
Abstract 20055: Serotonin Transporter Gene Polymorphism in Women with Suspected Ischemia: A Report from the NHLBI-sponsored WISE (2010) (5)
1172-76 Healthcare costs for cardiovascular disease in women with and without obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institutes-Sponsored Women's Ischemia Syndrome evaluation (WISE) (2004) (5)
Factors Influencing Clinical Outcomes After Revascularization in the Asymptomatic Cardiac Ischemia Pilot (ACIP) (1999) (5)
Asymptomatic cardiac ischemia pilot (ACIP). (1995) (5)
Variations in the application of exception from informed consent in a multicenter clinical trial. (2019) (5)
Effect of antihypertensive medications on physical work capacity (1981) (5)
Effect of physical conditioning on measures of thyroid hormone action. (1986) (5)
Exercise ECG test results in the TIMI II trial (1990) (5)
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE) (2020) (5)
IMPACT OF SURGICAL VENTRICULAR RECONSTRUCTION ON SPHERICITY INDEX IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY: FOLLOW-UP FROM STICH TRIAL (2014) (5)
Factors Influencing Clinical Outcomes After Revascularization in the Asymptomatic Cardiac Ischemia Pilot (ACIP) (1985) (4)
Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. (2018) (4)
TXA Administration in the Field Does Not Affect Admission TEG after Traumatic Brain Injury. (2020) (4)
Renal function and coronary bypass surgery in patients with ischemic heart failure. (2020) (4)
Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2013) (4)
Are we ‘WISE’r? Findings from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study (2006) (4)
2018 Annual Meeting Supplement. (2018) (4)
Relation Between Clinical, Angiographic and Ischemic Findings at Baseline and Ischemia-Related Adverse Outcomes at 1 Year in the Asymptomatic Cardiac Ischemia Pilot Study (2016) (4)
VARIATION IN TIME TO NOTIFICATION OF ENROLLMENT AND RATES OF WITHDRAWAL IN RESUSCITATION TRIALS CONDUCTED UNDER EXCEPTION FROM INFORMED CONSENT. (2021) (3)
Abstract 3: Prehospital Lactate for Identification of the Need for Resuscitative Care in Trauma Patients Transported by Air (2014) (3)
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE). (2016) (3)
Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT). (2011) (3)
Differential Impact of Mitral Valve Repair on Outcome of Coronary Artery Bypass Grafting with or without Surgical Ventricular Reconstruction in the Surgical Treatment for Ischemic Heart Failure (STICH) Trial (2019) (3)
Global health and emergency care: a resuscitation research agenda--part 2. (2013) (3)
Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE). (2017) (3)
Relation of patient characteristics to cardiac ischemia during daily life activity (an Asymptomatic Cardiac Ischemia Pilot Data Bank Study). (1996) (3)
Body weight and physical fitness in women with ischaemic heart disease: does physical fitness contribute to our understanding of the obesity paradox in women? (2022) (3)
LATE GADOLINIUM ENHANCEMENT AND ADVERSE CARDIAC EVENTS AT 1 YEAR FOLLOW-UP IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA AND NO OBSTRUCTIVE CORONARY DISEASE: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (2015) (3)
Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction (WISE-CVD) study (2021) (3)
B-TYPE NATRIURETIC PEPTIDE DOES NOT CORRELATE WITH INVASIVE OR NONINVASIVE MEASURES OF CORONARY MICROVASCULAR DYSFUNCTION IN WOMEN WITH PRESERVED EJECTION FRACTION: A REPORT FROM THE WOMEN'S ISCHEMIA SYNDROME EVALUATION- CORONARY VASCULAR DYSFUNCTION (WISE-CVD) STUDY (2014) (3)
Even “WISE-R?”—an Update on the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (2020) (3)
re-Hospital 12-Lead Electrocardiography Programs Call for Implementation by Emergency Medical Services (2006) (2)
Resuscitation outcomes consortium roc primed trial of early rhythm analysis versus later analysis in out-of-hospital cardiac arrest (2010) (2)
Abstract 18043: Identifying Predictors for All-Cause Mortality in Diabetic Patients in the ACCORD Trial Using Random Survival Forests (2017) (2)
The functional capacity and physical activity levels of women over 60 years of age. (1984) (2)
819-3 Coronary vascular dysfunction is only partially predicted by traditional cardiovascular risk factors in women undergoing evaluation for suspected ischemia: Results from the National Heart, Lung, and Blood Institute WISE study (2004) (2)
Research Acute Heart Failure Syndromes: Current State and Framework for Future (2006) (2)
PREVALENCE OF MYOCARDIAL SCAR IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA BUT NO OBSTRUCTIVE CORONARY ARTERY DISEASE: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (2015) (2)
The ESCAPE Discharge Risk Score: Don't Go Home without It (2006) (2)
Institutes of Health Committee; National Heart, Lung, and Blood Institute (NHLBI); National Life Support—National Heart Attack Alert Program (NHAAP) Coordinating Implementation by Emergency Medical Services Systems Providing Advanced Pre-Hospital 12-Lead Electrocardiography Programs: A Call for (2006) (2)
Maladaptive left ventricular remodeling in women: An analysis from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction study. (2018) (2)
Abstract 16636: Left Ventricular Function and Remodeling Early After Coronary Artery Bypass Grafting Compared With Medical Therapy: Results From the Surgical Treatment for Ischemic Heart Failure (STICH)Trial (2014) (2)
Abstract 19392: A Landmark Analysis of 30-day Mortality after Coronary Artery Bypass Surgery in Patients with Ischemic Heart Failure: Results of the Surgical Treatment for Ischemic Heart Failure (STICH) Trial (2014) (2)
N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study (2020) (2)
Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. (2017) (2)
Evidence-Based Guidelines for Cardiovascula r Disease Prevention in Women: 2007 Updat e (2007) (1)
The BARI trial: baseline observations. The BARI Investigators. (1993) (1)
Serotonin Transporter Gene Polymorphism in Women With Suspected Ischemia (2018) (1)
Working Group on Emergency Department Management of Acute Heart Failure Research Challenges and Opportunities (1)
MYOCARDIAL INFARCTION SYMPTOM PRESENTATION AND HOSPITAL MORTALITY: RELATIONSHIP TO AGE AND SEX IN THE NATIONAL REGISTRY OF MYOCARDIAL INFARCTION (NRMI) (2010) (1)
Abstract 20443: Sex-Specific Coronary Vascular Function Thresholds and Prognosis: A Report From the Women’s Ischemia Syndrome Evaluation (WISE) (2016) (1)
Abstract 10364: Noninvasive Detection of Microvascular Coronary Dysfunction Using Cardiac Magnetic Resonance Imaging: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study (2011) (1)
847-6 Serum inflammatory markers correlate with hemoglobin levels in women undergoing evaluation for suspected ischemia: Results from the national heart, lung, and blood institute WISE study (2004) (1)
Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women's Ischemia Syndrome Evaluation) Cohort. (2023) (1)
Abstract 16252: Predictors of All Cause Mortality and Their Gender Differences in a Hispanic Population From Barranquilla-Colombia Using Machine Learning With Random Survival Forests (2018) (1)
COULD RETINAL IMAGING PROVIDE A SIMPLE INEXPENSIVE NONINVASIVE INDEX FOR CORONARY MICROVASCULAR FUNCTION IN WOMEN WITH CHEST PAIN AND NONOBSTRUCTIVE CORONARY ARTERY DISEASE? AN ANCILLARY PILOT STUDY FROM THE NHLBI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE-ARIC) (2011) (1)
RELATIONSHIP BETWEEN CORONARY MICRO- AND MACROVASCULAR MEASURES IN WOMEN WITH CHEST PAIN WITHOUT SIGNIFICANT CORONARY ARTERY DISEASE: AN ANCILLARY SUBSTUDY FROM THE NHBLI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE) (2011) (1)
Risk factors for heart failure in women with ischemia and no obstructive coronary artery disease (2021) (1)
Periprocedure myocardial infarction rates in the bypass angioplasty revascularization investigation (BARI) (1996) (1)
Abstract 4178: Cardiovascular Event-Free Survival in Post-Menopausal Women with Polycystic Ovary Syndrome: Results from the Women's Ischemia Syndrome Evaluation (2006) (1)
Abstract 19568: African-American Ethnicity, Risk Variables, Coronary Artery Disease, and Long-Term Prognosis in Women: The National Heart, Lung, and Blood Institute Sponsored Women's Ischemia Syndrome Evaluation Study (2017) (1)
Bradykinin B1 receptor gene polymorphism is associated with impaired coronary reactivity in women: a report from the NHLBI WISE study (2002) (1)
Overview of percutaneous coronary catheter-based revascularization: past and present and the role of federal funding. (1993) (1)
DOES ANGIOTENSIN PLUS ALDOSTERONE INHIBITION IMPROVE CORONARY ENDOTHELIAL FUNCTION? AN ANCILLARY STUDY FROM THE NHLBI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE) (2011) (1)
Abstract 804: Sudden Cardiac Death and Severity of Obstructive Coronary Artery Disease: A Report From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study (2009) (1)
Adenosine vs Regadenoson Pharmacologic Stress Differs in Women with Suspected Coronary Microvascular Dysfunction: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) Study. (2019) (1)
CONSTRICTION OF THE BRACHIAL ARTERY DURING BRACHIAL ARTERY REACTIVITY TESTING PREDICTS MAJOR ADVERSE CLINICAL OUTCOMES IN WOMEN WITH SUSPECTED MYOCARDIAL ISCHEMIA: THE NHLBI-SPONSORED WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY (2010) (1)
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women Expert Panel / Writing Group * (2004) (1)
ANGINA AND MYOCARDIAL PERFUSION IMPROVE IN WOMEN WITH CORONARY MICROVASCULAR DYSFUNCTION AT 1 YEAR FOLLOW-UP: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (2015) (1)
Abstract 5580: Sex Differences in Outcomes after Myocardial Infarction with Persistent Total Occlusion of the Infarct Artery: Analysis of the Occluded Artery Trial (2008) (1)
INFLAMMATORY BIOMARKER IL-6 PREDICTS HEART FAILURE IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA AND NO OBSTRUCTIVE CORONARY ARTERY DISEASE: FINDINGS FROM THE NHLBI-SPONSORED WOMEN’S ISCHEMIC SYNDROME EVALUATION (WISE) STUDY (2016) (1)
Study Monitoring in Emergency Care Trials: Lessons from the Resuscitation Outcomes Consortium Continuous Chest Compressions Trial. (2019) (1)
Erratum: Trauma in the neighborhood: A geospatial analysis and assessment of social determinants of major injury in North America (American Journal of Public Health (2011) 101:4 (669-677)) (2011) (1)
DIFFERENCES IN ADENOSINE AND REGADENOSON ON MYOCARDIAL PERFUSION RESERVE INDEX: A REPORT FROM THE WOMEN'S ISCHEMIA SYNDROME EVALUATION-CORONARY VASCULAR DYSFUNCTION (WISE-CVD) STUDY (2014) (1)
Alzheimer's Disease-Related Dementias Summit 2022: National research priorities for the investigation of post-traumatic brain injury Alzheimer's Disease and Related Dementias. (2023) (1)
Abstract 18061: Predictors of Hospitalization or Death Due to Heart Failure in Diabetic Patients by Gender in the ACCORD Trial Using Random Survival Forests (2017) (1)
Abstract 19546: Differential Event Prediction Using Coronary Vascular Testing Results From the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation Study (2016) (1)
Abstract 02: Effect of Airway Insertion First-Pass Success Upon Patient Outcomes in the Pragmatic Airway Resuscitation Trial (2019) (1)
for routine exercise testing Risk stratification after successful coronary revascularization: the lack of a role (2011) (0)
Determinants of Brachial Artery Endothelial Function in Women: Pilot Phase Results From the WISE Clinical Centers (1998) (0)
SEX DIFFERENCES IN CARDIOVASCULAR DISEASE OUTCOMES IN RESPONSE TO FENOFIBRATE THERAPY IN TYPE 2 DIABETIC PATIENTS IN THE ACCORD LIPID STUDY (2018) (0)
Phytosetrogens have a potentially adverse effect on coronary vasodilator (endothelial independent) function in women with suspected ischemia: a report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study (2002) (0)
TraumaintheNeighborhood:AGeospatialAnalysisand AssessmentofSocialDeterminantsofMajorInjuryin NorthAmerica (2011) (0)
Persistent chest pain at 1-year predicts long-term angina hospitalization in women with and without obstructive coronary artery disease: results from Women's Ischemia Syndrome Evaluation (WISE) (2020) (0)
Comparative 5 year incidence of ischemic events for PTCA and CABG in the Bypass Angioplasty Revascularization Investigation (BARI) (1996) (0)
Abstract P152: Differences in Symptom Presentation According to Type of Acute Myocardial Infarction (2011) (0)
Nonwhite More than high school education History of diabetes Diabetes , using insulin History of dyslipidemia Current smoking History of hypertension History of congestive heart (2016) (0)
Prevalence of Congenital Cardiovascular Malformations in Children of Human Immunodeﬁciency Virus-Infected Women The Prospective P 2 C 2 HIV Multicenter Study (2016) (0)
Prognosis of patients without myocardial necrosis after thrombolytic therapy: A TIMI II data bank study (1991) (0)
Sampling the universe for the bypass angioplasty revascularization investigation (1991) (0)
Abstract 14469: Risk Factors for the Development of Heart Failure in Women Without Obstructive Coronary Artery Disease. A Follow Up Study From the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) (2016) (0)
PROGNOSTIC VALUE OF BASELINE CARDIOVASCULAR MAGNETIC RESONANCE IMAGING MEASURES OF LEFT VENTRICULAR GEOMETRY AND FUNCTION IN 366 PATIENTS UNDERGOING SURGERY FOR ISCHEMIC CARDIOMYOPATHY: RESULTS FROM NIH SPONSORED STICH TRIAL (2014) (0)
Women Versus Men Regarding Outcome of CABG or PTCA Response (1999) (0)
Directions: Report of the National Heart, Lung and Blood Institute Workshop: October 2 Women's Ischemic Syndrome Evaluation : Current Status and Future Research (2012) (0)
Angioplasty vs Bypass Surgery in Patients With Multivessel Coronary Artery Disease-Reply (1997) (0)
Cost implications for treatment of cardiac ischemia: An ancillary Asymptomatic Cardiac Ischemia Pilot (ACIP) study (1996) (0)
BRIEF REPORT Phytoestrogens and Lipoproteins in Women (2006) (0)
Inflammation is not associated with coronary microvascular dysfunction in women with chest pain (2003) (0)
Fitness Attenuates Long-term Cardiovascular Outcomes in Women with Ischemic Heart Disease and Metabolic Syndrome (2023) (0)
Abstract 2450: A Randomized Controlled Trial of Low Dose Hormone Therapy on Myocardial Ischemia in Postmenopausal Women with No Obstructive Coronary Artery Disease:Results from the NHLBI-sponsored WISE (2007) (0)
Abstract 626: Predictors of Hard Outcomes in the ALLHAT Trial Identified With Machine Learning (2019) (0)
Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease (2011) (0)
Abstract 3771: Type of Menopause, Hormone Therapy and Coronary Artery Disease in Women: New Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) (2007) (0)
Abstract 11580: Brachial Pulse Pressure Predicts Adverse Outcomes Including Heart Failure Hospitalizations in Women With Preserved Ejection Fraction and No Obstructive Coronary Artery Disease: A Report from the Women’s Ischemia Syndrome Evaluation (2014) (0)
Sustained Reduction in Symptoms Related to Reduction of Filling Pressures during Hospitalization for Heart Failure (2006) (0)
USE OF MACHINE LEARNING METHODOLOGY TO FIND PREDICTORS OF ALL-CAUSE MORTALITY IN PREVENTION OF EVENTS WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITION (PEACE) TRIAL (2020) (0)
Mildly reduced creatinine clearance is associated with coronary artery disease in women: The NHLBI-sponsored WISE study (2003) (0)
Abstract 391: Variation in Time to Notification After Enrollment in Trials Conducted Under Exception From Informed Consent for Emergency Research (2019) (0)
Abstract 13235: Mild Renal Insufficiency Predicts Mortality and Adverse Events in Women With Cardiac Ischemia, Independent of the Underlying Obstructive Coronary Artery Disease (2013) (0)
Determination of menopausal status in women The NHLBI-sponsored WISE study (1999) (0)
990-47 Absence of Ischemia on Ambulatory ECG Monitoring During Treatment as a Predictor of Outcome: A Report from the ACIP Study (1995) (0)
SEX DIFFERENCES IN PRESENTATION WITHOUT CHEST PAIN FOR CONFIRMED MYOCARDIAL INFARCTION ARE ATTENUATED WITH ADVANCING AGE IN THE NATIONAL REGISTRY OF MYOCARDIAL INFARCTION (NRMI) (2010) (0)
Do hot flashes explain the protective association between HRT and CAD in women: the NHLBI-sponsored WISE study (2002) (0)
HRT modulates brachial artery diameter and flow-mediated dilation: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study (2002) (0)
PREDICTORS OF ALL-CAUSE MORTALITY IN THE SPRINT TRIAL IDENTIFIED BY MACHINE LEARNING (2019) (0)
Abstract 1992: Evolution of the Pattern of Atherosclerosis Assessed by Intravascular Ultrasound in Women: A Substudy of the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2006) (0)
Does one-year outcome after acute myocardial infarction differ with race? Results from the TIMI II trial (1991) (0)
Development of New Views of Disease Left Ventricular Form and Function : Scientific Priorities and Strategic Planning for (2013) (0)
USE OF MACHINE LEARNING METHODOLOGY TO FIND PREDICTORS OF ALL-CAUSE MORTALITY IN THE SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT) (2020) (0)
Abstract 2842: CMR-Determined Regional Myocardial Perfusion Uptake Rate Predicts Events in Women Without Obstructive Coronary Artery Disease: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study (2006) (0)
918-20 Performance of Coronary Angioplasty in Patients with Multivessel Coronary Artery Disease: Observations from the Bypass Angioplasty Revascularization Investigation (BARI) (1995) (0)
ANGIOPLASTY VS BYPASS SURGERY IN PATIENTS WITH MULTIVESSEL CORONARY ARTERYDISEASE. AUTHOR'S REPLY (1997) (0)
Workshop Priorities for the Next Decade: Report From a National Heart, Lung, and Blood Institute Pulseless Electric Activity: Definition, Causes, Mechanisms, Management, and Research (2013) (0)
Abstract 19139: Effect of HDL-C Raising and/or Triglyceride Lowering on Cardiovascular Outcomes and All-Cause Mortality in the AIM-HIGH Trial (2016) (0)
OPTIMAL MEDICAL THERAPY USE AND LONG-TERM OUTCOMES IN CABG-ELIGIBLE HEART FAILURE PATIENTS: INSIGHTS FROM THE STICH TRIAL (2019) (0)
Abstract 18861: Gender Differences in Hospitalization or Death Due to Heart Failure as Related to Glycemic Control in the ACCORD Trial (2016) (0)
Abstract 15650: Hospital Variation in the Use of Targeted Temperature Management for Out-of-Hospital Cardiac Arrest (2017) (0)
Sample size calculation for clinical trials in which entry criteria and outcomes are counts of events. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot. (1994) (0)
IDENTIFYING PREDICTORS OF HOSPITALIZATION DUE TO HEART FAILURE IN THE TOPCAT TRIAL USING MACHINE LEARNING TECHNIQUES (2019) (0)
Can a pre-exercise test score predict prognosis in women with a low prevalence of coronary disease? The National heart, lung, and blood institute- sponsored women's ischemia syndrome evaluation (WISE) study (2003) (0)
Mueller et al TIMI II Subgroup Analyses : Predictors of Early Events 1255 factors for early death in patients with AMI treated with thrombolytic therapy . The Thrombolysis in Myocardial Infarction ( TIMI ) phase (2005) (0)
Abstract 20878: Increasing Bystander AED Use at ROC Sites in Out-of-Hospital Cardiac Arrest From 2005-2015 (2017) (0)
Clinical Practice Patterns and Bias in Randomized Trials: A Survey of Investigators in the BEST-CLI Trial (2019) (0)
DIET, ANGIOGRAPHIC CORONARY DISEASE, AND CARDIOVASCULAR OUTCOMES IN WOMEN (2022) (0)
Women2011 Update: A Guideline From the American Heart Association Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in (2011) (0)
Using estimated functional capacity to optimize stress testing for diagnosis and prognosis of cardiovascular disease in women: The NHLBI-sponsored WISE study (2003) (0)
PREDICTORS OF ALL-CAUSE MORTALITY IN THE BARI 2D TRIAL IDENTIFIED BY MACHINE-LEARNING (2019) (0)
Abstract 17059: Re-Use of Clinical Trial Data From the NHLBI Data Repository (BioLINCC) for Patient-Level Meta-Analyses of Cardiovascular Outcomes: Challenges and Opportunities (2018) (0)
BEST‐CLI Site Performance Comparison Between Multidisciplinary Sites and Nonmultidisciplinary Sites (2019) (0)
USE OF MACHINE LEARNING METHODOLOGY TO FIND PREDICTORS OF ALL-CAUSE MORTALITY IN THE TREATMENT OF PRESERVED CARDIAC FUNCTION HEART FAILURE WITH AN ALDOSTERONE ANTAGONIST TRIAL (TOPCAT) (2020) (0)
RISK OF HOSPITALIZATION OR DEATH DUE TO HEART FAILURE WITH INTENSIVE GLUCOSE-LOWERING THERAPY IN DIABETIC WOMEN: SUBGROUP ANALYSES BY HISTORY OF CARDIOVASCULAR DISEASE IN THE ACCORD TRIAL (2017) (0)
PERICARDIAL FAT VOLUME IS RELATED TO ENODTHELIAL-MEDIATED CORONARY BLOOD FLOW IN WOMEN WITH SUSPECTED CORONARY MICROVASCULAR DYSFUNCTION: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION - CORONARY VASCULAR DYSFUNCTION (WISE-CVD) STUDY (2016) (0)
Abstract 17121: Predictors of Death and Major Adverse Cardiovascular Events in the ACCORD Trial Identified by Random Survival Forest Based Machine-Learning (2018) (0)
Abstract 313: Assessment of Arrest Procedures, Hospital Care and Functional Survival of Initial VT/VF Arrest Patients Shocked by a Bystander AED vs Patients Shocked by EMS (2013) (0)
Consortium Population of 21 Million of the Emergency Medical System: Evaluation in the Resuscitation Outcomes Survival After Application of Automatic External Defibrillators Before Arrival (2010) (0)
Bystander AED Use is of Particular Value in Public Locations where VT/VF is More Frequent(Special Lecture 9,The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
Patients With Systolic Heart Failure and Coronary Artery DiseaseClinical Influence of Crossover on Mortality in a Randomized Study of Revascularization (2013) (0)
Abstract 2813: Causes of Death in Early MI Survivors With Persistent Vessel Occlusion: Results from the Occluded Artery Trial (OAT) (2007) (0)
Abstract 246: Chest Compression Rates Used During Out-of-Hospital Cardiopulmonary Resuscitation in Nine Resuscitation Outcomes Consortium Regional Sites (2010) (0)
Patients Ran&&&d to Coronary Artery Bypass Surgery in the Bypass Angioplasty Revascularization Investigation (BARI) (1995) (0)
Abstract 2560: Reduction of Filling Pressures During Hospitalization Predicts Sustained Reduction in Heart Failure Symptoms (2006) (0)
PREDICTORS OF ALL-CAUSE MORTALITY IN THE AIM-HIGH TRIAL IDENTIFIED BY MACHINE LEARNING (2019) (0)
Role of physical fitness in the obesity paradox. Long-term major adverse cardiovascular events in the Women's Ischemia Syndrome Evaluation (WISE) (2020) (0)
Abstract 17031: Renal Microvascular Dysfunction is Related to Endothelial-Dependent Coronary Microvascular Dysfunction: a Report From the Women’s Ischemia Syndrome Evaluation (2014) (0)
Re: "Dietary measures of physical activity". (1986) (0)
MYOCARDIAL SCAR PATTERNS IN WOMEN WITH SUSPECTED CORONARY VASOMOTOR DYSFUNCTION: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (2018) (0)
Abstract 3358: Multibiomarker Approach Predicts Adverse Cardiovascular Outcomes in Women Evaluated for Suspected Ischemia without Obstructive CAD Better than Traditional Risk Predictors: Results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) (2006) (0)
RELATIONSHIP OF PHYSICAL FITNESS AND METABOLIC SYNDROME TO 10-YEAR MORTALITY IN WOMEN: A REPORT FROM THE WOMEN's ISCHEMIA SYNDROME EVALUATION STUDY (2020) (0)
IN WOMEN WITH SYMPTOMS OF CARDIAC ISCHEMIA, NONOBSTRUCTIVE CORONARY ARTERIES AND MICROVASCULAR DYSFUNCTION, ACE INHIBITION IS ASSOCIATED WITH IMPROVED MICROVASCULAR FUNCTION: A DOUBLE-BLIND RANDOMIZED ANCILLARY STUDY FROM THE NHLBI WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) (2010) (0)
Abstract 18242: Maladaptive Remodeling in Women with Signs and Symptoms of Ischemia and Elevated Left Ventricular End-diastolic Pressure (2014) (0)
1119-94 Reduced functional capacity in women is associated with impaired vascular function (2004) (0)
EFFECT OF PHOSPHODIESTERASE TYPE 5 (PDE-5) INHIBITION ON CORONARY MICROVASCULAR DYSFUNCTION IN WOMEN: AN ANCILLARY STUDY FROM THE NHLBI-SPONSORED WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) (2010) (0)
Abstract 3649: Menstrual Cycling and Mechanisms of Cardiovascular Disease Events in Post-Menopausal Women: Results from the NIH-NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2007) (0)
Anemia and Long-term cardiovascular outcomes in women with suspected ischemia – The Women's Ischemia Syndrome Evaluation (WISE) (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With George S. Sopko?

George S. Sopko is affiliated with the following schools:

George S. Sopko's Academic­Influence.com Rankings

George S. Sopko's Degrees

Similar Degrees You Can Earn

Why Is George S. Sopko Influential?

George S. Sopko's Published Works

Published Works

What Schools Are Affiliated With George S. Sopko?

George S. Sopko's AcademicInfluence.com Rankings